CompaniesMolecular Diagnostics, Inc

Molecular Diagnostics, Inc

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

6

As Collaborator

0

Total Enrollment

9,462

By Phase

NA: 1

By Status

COMPLETED: 4UNKNOWN: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT01005030
NCT01787227
NCT03581578
Hover over trial bars to see details

Recent Trials

NCT03581578Lead Sponsor
VITROS Immunodiagnostic Products hs Troponin I
N/AUnknown
1,630 participants
Started: Jun 7, 2018 · Completed: Jun 30, 2021
NCT03548909Lead Sponsor
VITROS Immunodiagnostic Products NT-proBNP II
N/ACompleted
3,246 participants
Started: Jun 6, 2018 · Completed: Oct 17, 2019
NCT02862262Lead Sponsor
A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients
NACompleted
1,052 participants
Started: Jul 31, 2016 · Completed: Nov 14, 2016
NCT01787227Lead Sponsor
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel
N/ACompleted
1,500 participants
Started: Jan 31, 2015
NCT01326013Lead Sponsor
A Two-Arm, Multi-Centre Clinical Evaluation of the xTAG Gastrointestinal Pathogen Panel
N/ACompleted
1,534 participants
Started: Jun 30, 2011 · Completed: Mar 31, 2012
View all 6 trials →